Alx Oncology Hldgs Inc (ALXO) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Alx Oncology Hldgs Inc (ALXO) following the 2026 Q2 hedge fund 13F filings?

As of today, ALXO has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), ALXO gained -3.9% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Alx Oncology Hldgs Inc (ALXO)

69 + Investors. Track Smart Money conviction in ALXO. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ALXO

Based on 69 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added ALXO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🔻

Below peak — only 63% of 3.0Y high

63% of all-time peak

Only 69 funds hold ALXO today versus a peak of 109 funds at 2024 Q2 — just 63% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.

📉

Outflows — 18% fewer funds vs a year ago

fund count last 6Q

15 fewer hedge funds hold ALXO compared to a year ago (-18% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟢

More buyers than sellers — 65% buying

45 buying24 selling

Last quarter: 45 funds were net buyers (25 opened a brand new position + 20 added to an existing one). Only 24 were sellers (12 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter

Funds opening a new ALXO position: 10 → 8 → 7 → 25. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

46% of holders stayed for 2+ years

■ 46% conviction (2yr+) ■ 25% medium ■ 29% new

32 out of 69 hedge funds have held ALXO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +464% but shares only +222% — price-driven

Value

+464%

+222%

Last quarter: the total dollar value of institutional holdings rose +464%, but actual share count only changed +222%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

9 → 10 → 8 → 7 → 25 new funds/Q

New funds entering each quarter: 10 → 8 → 7 → 25. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 56% veterans vs 27% newcomers

■ 56% veterans ■ 17% 1-2yr ■ 27% new

Entry-cohort mix of 71 holders: 40 (56%) are 2+ year veterans, 12 entered 1–2 years ago, and 19 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 7% AUM from top-100

7% from top-100 AUM funds

20 of 68 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

1.9

out of 10

Low Exit Risk

Exit risk score 1.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	69	56	23.21%
13F Shares	95M	29M	222.45%
Total Value	$188M	$33M	463.95%
New Positions	25	7	+18
Increased Positions	18	18	-
Closed Positions	12	12	-
Reduced Positions	11	15	-4
Total Calls	2	3	-33.33%
Total Puts	1	3	-66.67%
PUT/CALL Ratio	0.5	1.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

23.21%

13F Shares

95M

29M

222.45%

Total Value

$188M

$33M

463.95%

New Positions

+18

Increased Positions

Closed Positions

Reduced Positions

-4

Total Calls

-33.33%

Total Puts

-66.67%

PUT/CALL Ratio

0.5

1.0

Bullish

Institutional Holders (2026 Q2)

69 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ALXO. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ALXO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Silverarc Capital Management, LLC	1.24%	5,744,757	$11.9M
2	EntryPoint Capital, LLC	0.31%	76,415	$461K
3	HC Advisors, LLC	0.03%	22,900	$47K
4	Axq Capital, LP	0.01%	40,553	$84K
5	JSF Financial, LLC	0.01%	17,500	$36K
6	Marshall Wace, LLP	0.01%	3,071,496	$6.4M
7	Abel Hall, LLC	0.00%	12,731	$26K
8	Bronte Capital Management Pty Ltd.	0.00%	18,095	$37K
9	Renaissance Technologies LLC	0.00%	603,797	$1.2M
10	Ieq Capital, LLC	0.00%	175,382	$363K
11	China Universal Asset Management Co., Ltd.	0.00%	12,500	$26K
12	Bradley & Co. Private Wealth Management, LLC	0.00%	1,000	$2K
13	Callan Family Office, LLC	0.00%	22,419	$46K
14	Ameritas Investment Partners, Inc.	0.00%	9,792	$20K
15	Tower Research Capital LLC (TRC)	0.00%	10,397	$22K
16	Police & Firemen's Retirement System of New Jersey	0.00%	31,822	$66K
17	Intech Investment Management LLC	0.00%	19,424	$40K
18	Vanguard Fiduciary Trust Co	0.00%	743,491	$1.5M
19	BlackRock, Inc.	0.00%	7,399,530	$15.3M
20	Vanguard Capital Management LLC	0.00%	4,973,436	$10.3M
21	Rhumbline Advisers	0.00%	107,902	$223K
22	Wealth Enhancement Advisory Services, LLC	0.00%	38,011	$81K
23	Xponance LLC	0.00%	10,179	$21K
24	Jpmorgan Chase & Co	0.00%	1,044,728	$2.3M
25	UBS Group AG	0.00%	462,943	$958K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Alx Oncology Hldgs Inc (ALXO)

What does the Smart Money Trend signal show for ALXO?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ALXO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ALXO?

More buyers than sellers — 65% buying: Last quarter: 45 funds were net buyers (25 opened a brand new position + 20 added to an existing one). Only 24 were sellers (12 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ALXO holders?

Smaller funds dominant — 7% AUM from top-100: 20 of 68 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ALXO?

46% of holders stayed for 2+ years: 32 out of 69 hedge funds have held ALXO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Alx Oncology Hldgs Inc (ALXO) following the 2026 Q2 hedge fund 13F filings?

As of today, ALXO has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), ALXO has gained -3.9% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Alx Oncology Hldgs Inc (ALXO)

Smart Money Signals — ALXO

Buying streak — 1 quarter in a row

Below peak — only 63% of 3.0Y high

Outflows — 18% fewer funds vs a year ago

More buyers than sellers — 65% buying

More new buyers each quarter (+18 vs last Q)

46% of holders stayed for 2+ years

Value +464% but shares only +222% — price-driven

Acceleration phase — new buyers rushing in

Veteran-anchored — 56% veterans vs 27% newcomers

Smaller funds dominant — 7% AUM from top-100

Institutional Sentiment Summary — ALXO

Hedge Fund Ownership: ALXO

Market Analysis: ALXO

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ALXO

Is It Too Late to Buy Alx Oncology Hldgs Inc (ALXO) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ALXO

Statistics: ALXO

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Alx Oncology Hldgs Inc (ALXO)

Welcome to 13Foresight!